Xpovio (Selinexor) Made Simple! Join Dr. Joseph Mikhael to learn about Xpovio® (Selinexor), a groundbreaking drug in the treatment of myeloma, belonging to a new class of drugs called XPO1 inhibitors. This innovative medication targets myeloma cells by blocking a pathway called XPO1, keeping important tumor suppressors inside the nucleus and reducing the risk of cancerous cell growth. Selinexor has shown remarkable efficacy, even in heavily treated patients, offering a new approach to combating myeloma.
This episode of the Myeloma Made Simple Series is supported by Karyopharm Therapeutics.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! fundraise.myeloma.org/give/52...
Category
Nonprofits & Activism
License
Standard KZitem License
In most cases, captions are autogenerated by KZitem.
Негізгі бет Myeloma Made Simple: Xpovio (Selinexor) Made Simple | Selinexor for Multiple Myeloma Treatment
Пікірлер: 2